Anti-GAD65 + GAD67 antibody [EPR19366],Abcam,AB183999

Anti-GAD65 + GAD67 antibody [EPR19366] (ab183999) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in ICC/IF, IHC-Fr, IHC-P, IP, WB in human, mouse, rat samples. Anti-GAD65 + GAD67 antibody [EPR19366] (ab183999) has been cited over 17 times in peer reviewed journals and is trusted by the scientific community. Abcams high quality manufacturing and validation processes ensure Anti-GAD65 + GAD67 antibody [EPR19366] (ab183999) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. Anti-GAD65 + GAD67 antibody [EPR19366] (ab183999) has 4 independent reviews from customers. Anti-GAD65 + GAD67 antibody [EPR19366] (ab183999) specifically detects GAD65 + GAD67 (UniProt ID: P48318; Molecular weight: 67kDa) and is sold in 100 uL and 1 mL selling sizes. Conjugation-ready, carrier free format available for antibody clone EPR19366 - ab2428 . Antibody clone EPR19366 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 647, Biotin, Alexa Fluor® 488 ( ab313591 , ab314398 , ab314811 ). Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .